Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure Francisco J. Blanco; Esteban Rubio-Romero; Raimon Sanmartí; César Díaz-Torné; Pablo Talavera; Jochen Dunkel; Esperanza Naredo;

Integrating different perspectives to define a concept of comprehensive remission in rheumatoid arthritis: The SUMAR project Alejandro Balsa; José Luis Andreu; Juan Carlos Hermosa-Hernán; Josefa León-Navarro; Jordi Nicolas Pico; José Javier Pérez Venegas; Susana Romero-Yuste; Raimon Sanmarti; Antonio Ignacio Torralba Gómez-Portillo; Juan Carlos Valenzuela-Gámez; Jordi Cohen;

TNF¿-inhibitors cycling with golimumab as second drug in inflammatory arthritis patients: Data from the multicenter GO-REAL registry Carolina Ayelen Isnardi; Emma Estela Civit De Garignani; Agustín García Ciccarelli; Jimena Sanchez Alcover; Ingrid Strusberg; Marcos Baravalle; Sol Castaños; Liliana Morales; Matias Palombo; Eduardo Albiero; Carla Gobbi; Rodrigo Garcia Salinas; Sebastian Magri; Edson Velozo; Enrique R. Soriano; Alfredo Vargas Caselles; Luis Carlos Palomino Romero; Sergio Paira; Romina Calvo; Alberto Ortiz; María Julieta Gamba; Rodolfo Perez Alamino; Hernan Maldonado Ficco; Gustavo Citera;